Amanote Research
Register
Sign In
646. Human Bone Marrow-Derived Mesenchymal Stem Cells for Intranasal Delivery of Oncolytic Herpes Simplex Virus Type I to Human Gliomas
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34981-4
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
TGF- Mediates Homing of Bone Marrow-Derived Human Mesenchymal Stem Cells to Glioma Stem Cells
Cancer Research
Cancer Research
Oncology
Comparison of Human Placenta- And Bone Marrow–Derived Multipotent Mesenchymal Stem Cells
Stem Cells and Development
Developmental Biology
Hematology
Cell Biology
Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Comparison of Immunological Characteristics of Mesenchymal Stem Cells Derived From Human Embryonic Stem Cells and Bone Marrow
Tissue Engineering - Part A.
Biochemistry
Bioengineering
Biomedical Engineering
Biomaterials
Bone-Marrow-Derived Mesenchymal Stem Cells for Organ Repair
Stem Cells International
Cell Biology
Molecular Biology
Differential Gene Expression Profiling of Human Bone Marrow-Derived Mesenchymal Stem Cells During Adipogenic Development
BMC Genomics
Biotechnology
Genetics
Effective Genetic Modification of Human Bone Marrow-Derived Mesenchymal Stem Cells Upon Control Delivery of Raav Vectors via Carbon Dot Nanocarriers
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Nanostructured TiO2 Surfaces Promote Human Bone Marrow Mesenchymal Stem Cells Differentiation to Osteoblasts
Nanomaterials
Materials Science
Chemical Engineering
Treatment of Human Hepatocellular Carcinoma by the Oncolytic Herpes Simplex Virus G47delta
Cancer Cell International
Cancer Research
Oncology
Genetics
